Quick Answer
Corvus Pharmaceuticals, Inc. reported Net Income of -$15.28 million for fiscal year 2025.
Corvus Pharmaceuticals, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$15.28M | +75.5% |
| 2024 | -$62.29M | -130.5% |
| 2023 | -$27.03M | +34.6% |
| 2022 | -$41.31M | +4.5% |
| 2021 | -$43.24M | -621.3% |
| 2020 | -$6.00M | +87.2% |
| 2019 | -$46.67M | +0.6% |
| 2018 | -$46.94M | +15.7% |
| 2017 | -$55.66M | -53.0% |
| 2016 | -$36.38M | -16.1% |
| 2015 | -$31.34M | -19362.7% |
| 2014 | -$161.0K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$10.16M | +74.7% | -27.0% |
| June 30, 2025 | -$8.00M | -87.7% | -152.6% |
| March 31, 2025 | $15.19M | +366.5% | +137.8% |
| September 30, 2024 | -$40.22M | -570.3% | -843.6% |
| June 30, 2024 | -$4.26M | +34.5% | +25.2% |
| March 31, 2024 | -$5.70M | +27.6% | +5.0% |
| September 30, 2023 | -$6.00M | +59.5% | +7.7% |
| June 30, 2023 | -$6.50M | +22.2% | +17.4% |
- Corvus Pharmaceuticals, Inc. showed an increase of +75.5% in Net Income compared to the prior fiscal year.
- Over the 2014–2025 period, Corvus Pharmaceuticals, Inc.’s net income has declined by 9392.5% (from -$161.0 thousand to -$15.28 million).
- The most recent figure is from Corvus Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: